Shahla Karim Baloch et al.
Chirality, 27(3), 274-280 (2015-02-11)
In this study, a shikonin ester derivative, compound , was selected to evaluate its anticancer activities and we found that compound exhibited better antitubulin activities against the human HepG2 cell line with an IC50 value of 1.097 μM. Furthermore, the inhibition